Navigation Links
Avicena Announces Positive Phase II Data for a Combination Trial Involving AL-08 for the Treatment of Amyotrophic Lateral Sclerosis (ALS)
Date:12/3/2007

ference in the ALS- Functional Score between the therapies tested was large enough, and comparison to the historical controls was non-futile at the 6-month time point, we were able to finish the trial early after just 60 patients," stated Dr. Gordon. "We originally planned to enroll up to 120 patients, in sequential pools of 60. Our ability to halt the trial early underscores the potential efficacy of AL-08, which can be further evaluated in a Phase III ALS clinical trial."

"We are pleased that AL-08/celecoxib slowed deterioration in ALS- Functional Score compared to the other treatment and believe that results of this trial highlight the potential of this combination treatment for ALS patients," stated Belinda Tsao Nivaggioli, CEO and Chairman of Avicena. "We are eager to proceed with designing our Phase III clinical trial which will attempt to confirm the efficacy of AL-08".

About the Trial

The randomized, double-blind, selection trial targeted enrollment of up to 120 patients in sequential pools of 60 to evaluate the neuroprotective capacity of two drug combinations, AL-08/ minocycline and AL-08/celecoxib. The trial used a group sequential design and a natural history control group for a futility analysis. The primary objective was treatment selection based on which drug combination appeared to slow deterioration in the ALS-Functional Score.

Patients were randomized to receive daily administration of AL- 08/minocycline or AL-08/celecoxib. The trial was stopped early after the first pool of 60 patients when the selection criteria was met by showing a large enough difference in ALS-Functional Score between the two treatment arms.

Results showed that patients treated with AL-08/celcoxib showed a smaller mean functional decline versus AL-08/minocycline. At the end of the trial, the decline in ALS-Functional Score in both treatment arms was compared separately to the mean historical control group at a 0.05 significance level. The mea
'/>"/>

SOURCE Avicena Group, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Avicena Scientific Collaborator Advances Program for Using Energy Enhancing Molecules to Treat Neuromuscular Diseases
2. Survival Data for Avicenas Amyotrophic Lateral Sclerosis Drug Candidate, AL-02, to be Presented at 18th International Symposium on ALS/MND
3. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
4. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
5. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
6. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
7. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
8. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
9. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
10. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
11. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/1/2014)... Aug. 1, 2014 Research and ... "Global Medical Biosensors Market 2014-2018" report ... http://photos.prnewswire.com/prnh/20130307/600769 Medical biosensors are used ... physicochemical detectors. These biosensors monitor health status, disease ... non-invasive methods. They are cost-effective and user-friendly devices. ...
(Date:8/1/2014)... PALO ALTO, Calif. , Aug. 1, 2014 ... today announced a partnership to expand awareness of proper ... the CFChef Shares program. CFChef Shares will run from ... AbbVie,s CFChef program – an online resource for CF ... a healthy diet by submitting recipes to the ...
(Date:8/1/2014)... -- According to the new research ... infective), Basic (Films, Cleansing), Advanced (Hydrogels, Hydrocolloids, Alginate, ... Relief Devices, NPWT) - Global Forecast to 2019" ... expected to reach $18.3 Billion by 2019 from ... of 3.2% from 2014 to 2019. ...
Breaking Medicine Technology:Global Medical Biosensors Market 2014-2018: Key Vendors are Abbott, Bayer, LifeScan and F. Hoffmann-La Roche 2AbbVie and Cystic Fibrosis Research, Inc. (CFRI) Team Up to Raise Awareness of the Nutritional Needs of CF Patients through the CFChef Shares Program 2AbbVie and Cystic Fibrosis Research, Inc. (CFRI) Team Up to Raise Awareness of the Nutritional Needs of CF Patients through the CFChef Shares Program 3Wound Care Market Worth $18.3 Billion by 2019 2Wound Care Market Worth $18.3 Billion by 2019 3
... Stiefel, a GSK company, today announced the launch of the ... the United States. The launch will occur in the technical ... New Orleans. Indicated for the treatment of acne, Stiefel will ...   PanOxyl ® Acne Creamy Wash will be available in ...
... MEDfx Corporation today announced a Direct Project pilot that ... of the standards and protocols supported by the Direct ... in, and is a contributor to, the nationally-sponsored Direct ... Health IT.  The MEDfx Direct pilot will be demonstrated ...
Cached Medicine Technology:Stiefel Launches Most-Prescribed BPO Wash Formulations Over-the-Counter 2MEDfx to Harmonize the Direct Project With CONNECT 2MEDfx to Harmonize the Direct Project With CONNECT 3
(Date:8/1/2014)... Albany, NY (PRWEB) August 01, 2014 ... Surgical Generators Market Outlook to 2020", provides ... Surgical Generators market. The report provides value, ... units) and average prices (in US dollars) ... Electrocautery Generators, Ultrasonic Generators and Argon Plasma ...
(Date:8/1/2014)... August 01, 2014 Oxford Gene ... develops biomarkers. Its products include CytoSure heamatological cancer ... Array, CytoSure ISCA UPD array, CytoSure ISCA sample ... OGT offers services, such as targeted sequencing services, ... miRNA analysis, gene expression analysis, cytosure services and ...
(Date:8/1/2014)... In today’s age, traditional learning methods are futile ... these methods need to be revamped, so that the ... In this age of the internet, online learning resources ... learning management systems help in the planning, implementation, and ... these are proving to be very useful and this ...
(Date:8/1/2014)... Doheny HealthDay Reporter ... pills containing high doses of estrogen, along with some ... in women under 50, new preliminary research suggests. ... researcher Elisabeth Beaber, a staff scientist at the Fred ... formulations increase breast cancer risk while other formulations do ...
(Date:8/1/2014)... Women who serve in the U.S. military are less ... new study suggests. Overall, members of the military ... found that women respond differently to their experience in ... concerns about sexual harassment or being treated unfairly, they ... assault, both within and outside the military, and women ...
Breaking Medicine News(10 mins):Health News:United Kingdom Surgical Generators Market Size, Share, Analysis, Trends and Forecasts 2020 2Health News:United Kingdom Surgical Generators Market Size, Share, Analysis, Trends and Forecasts 2020 3Health News:Oxford Gene Technology Market Size, Share, Analysis, Trends and Forecasts 2014 2Health News:Oxford Gene Technology Market Size, Share, Analysis, Trends and Forecasts 2014 3Health News:North America Learning Management System Market is Expected to Reach $5.13 Billion in 2018 - New Report by MicroMarket Monitor 2Health News:North America Learning Management System Market is Expected to Reach $5.13 Billion in 2018 - New Report by MicroMarket Monitor 3Health News:North America Learning Management System Market is Expected to Reach $5.13 Billion in 2018 - New Report by MicroMarket Monitor 4Health News:Some Birth Control Pills May Up Breast Cancer Risk 2Health News:Some Birth Control Pills May Up Breast Cancer Risk 3Health News:Women in Military Drink Less Than Civilians, Report Shows 2
... died during the first days of January and many ... tuberculosis//. ,This was disclosed by the ... Indigenous Peoples' Organization (Opittamp), Elton Rodrigues Paes, who has ... the necessary treatment to the peoples in the River ...
... this week we’re looking at efforts to fight malaria. One ... IRS//. Insecticides are applied to the interior walls of homes ... disease. With IRS, protection can be guaranteed for up ... who chairs a U.N. Committee on Science and Technology and ...
... Researchers at UT Southwestern Medical Center have found a new ... to turn on genes could lead to therapeutics// for conditions ... This gene-activating method provides researchers with a novel research tool ... ,In a paper appearing online at Nature ...
... Medical School researchers report that a single protein in brain ... to insulin// and leptin, and energy balance. Their research findings ... cells were reported in the February issue of the Journal ... early to say how this protein could be useful in ...
... Government has come down heavily on alternative therapists who ... are about one lakh therapists said to exist in ... tab on these professionals. On the other hand, completely ... Medical Council have strict rules and guidelines regarding their ...
... announced that it is teaming up with Weight Watchers for ... fight obesity in more than 75000 people in the Mountain ... are eligible to take up this 16-week course from Weight ... points to different foods. This program is free, but participants ...
Cached Medicine News:Health News:Malaria and TB Kills Indian Kids in Brazil 2Health News:IRS Helps Curb Malaria in the Tropics 2Health News:A Novel Technique Nudges Genes Into Activity 2Health News:A Novel Technique Nudges Genes Into Activity 3Health News:A Protein in Brain Cells Controls Obesity: Research 2Health News:A Protein in Brain Cells Controls Obesity: Research 3Health News:A Protein in Brain Cells Controls Obesity: Research 4
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: